Some new variants of SARS-CoV-2 they have been elusive against antibodies under laboratory conditions, much to the concern of many researchers. Fortunately, our defenses go much further. A prepublication pending peer review shared this week concludes that the British, South African, Brazilian and Californian variants have a “negligible” effect on another arm of the immune system: T lymphocytes.
Evolutionary convergence or dead end? Why the coronavirus always mutates in the same way